AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06162429 — intervention group
Intervention type: PROCEDURE
Intervention: Semi-Rigid Pleuroscopy
Description: Subjects with pleural effusion who underwent medical thorascopy using semi-rigid pleuroscopy
Study NCT05741658 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dapagliflozin 10mg Tab
Description: Participants will take one Dapagliflozin 10mg tablet once per day for 4 weeks.
Study NCT06348186 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Guidebook
Description: Folder that will be given to the participant to carry out 5 minutes of intervention daily
Study NCT06348186 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Guidebook and Myofascial Reorganization® (RMF).
Description: The intervention will be carried out once a week for 30 minutes for 6 weeks. It will include passive, active-assisted moments (with and without load). In addition to a folder that will be given to the participant to carry out 5 minutes of intervention daily.
Study NCT04952168 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Almonertinib
Description: All patients were treated with Almonertinib 110 mg once a day for 3 months. Patients evaluated as CR, PR and SD were given concurrent chemoradiotherapy. The dose of radiotherapy was 60-66Gy/30-33F, After the end of concurrent chemoradiotherapy, the patients were treated with 110 mg of ametinib once a day until the disease progressed or the side effects were intolerable.
Study NCT06060418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aromtherapy
Description: aromatherapy with essential oil is being used as a non-pharmacological nursing intervention within the health care setting. This approach aims to manage the patient's discomfort and alleviate the symptoms of postoperative nausea and vomiting. One of the most beneficial oils is Lavender Essential Oil (LEO), which is used to treat a variety of digestive issues.
Study NCT05946798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylcholine
Description: acetylcholine is perfused at 10 ascending concentrations (10\^-10M - 10\^-1 M) for 5 minutes each
Study NCT05946798 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acetylcholine
Description: acetylcholine is perfused at 10 ascending concentrations (10\^-10M - 10\^-1 M) for 5 minutes each
Study NCT05946798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin aspart
Description: insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each
Study NCT05946798 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Insulin aspart
Description: insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each
Study NCT05534633 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Choice of STBBI test(s)
Description: Participants may receive a point of care HIV test, and/or point of care HCV test, and/or dry blood spot test, which can test for HIV, HCV, and syphilis, at the participants' choice.
Study NCT06582251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-intensity functional training
Description: Participants assigned to this group will undergo 8 weeks of high-intensity functional training.
Study NCT06582251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional resistance training
Description: Participants assigned to this group will undergo 8 weeks of traditional strength and hypertrophy training.
Study NCT06582251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent training
Description: Participants assigned to this group will undergo 8 weeks of traditional strength and hypertrophy training followed by high-intensity interval aerobic training.
Study NCT05555264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Guided
Description: Clients who select or are assigned the self-guided condition will be able to contact the Online Therapy Unit regarding any technical issues through the secure treatment platform; monitoring staff will respond by secure message to messages received however, no psychological intervention will be provided by monitoring staff as part of the ACCE treatment intervention. If there is a significant clinical issue requiring attention (e.g., a sudden increase in symptoms) monitoring staff will make a telephone call and crisis support will be provided if necessary.
Study NCT05555264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapist-Guided
Description: Therapists will spend \~15 minutes/week communicating with each client who selects the therapist-guided condition, primarily using secure messages. Phone calls will only be made if there is a significant clinical issue requiring attention that the therapist does not feel can be addressed in a message (e.g., a question about the materials that cannot be easily addressed in a text format, a sudden increase in symptoms, increased suicide risk).
Study NCT06102174 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06102174 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active
Description: Sisunatovir
Study NCT05209178 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Collection of nasal and oropharyngeal specimen for COVID19 antigen test
Description: Regarding two independent sampling procedures from the anterior part of the nose and the oropharynx, participants are randomized to either perform the sampling by themselves with written instructions or having the procedure performed by trained personnel. The specimen is meant for a rapid antigen test for COVID-19 infection.
Study NCT05209178 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Collection of nasal and oropharyngeal specimen for COVID19 antigen test
Description: Regarding two independent sampling procedures from the anterior part of the nose and the oropharynx, participants are randomized to either perform the sampling by themselves with written instructions or having the procedure performed by trained personnel. The specimen is meant for a rapid antigen test for COVID-19 infection.
Study NCT06668194 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Light Force (150g Niti Coil)
Description: Patients' participation in the study (T0) will be started at the stage of canine retraction. At this appointment, 0.019 x 0.025-inch stainless steel archwire will be placed; power arms will be fabricated from 17x25-inch stainless steel on the maxillary first molars and canines. The height of the power arm will be matched with the center of resistance of both canines and molars based on the root length measured on the periapical radiographs. The archwire will be engaged in the canine bracket using stainless steel ligature wire. NiTi coil spring calibrated for force magnitude (150g) at oral temperature will be used to deliver the assigned force will be engaged from the first molars to the canine power arms
Study NCT06668194 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heavy Force (400 g Niti coil)
Description: Patients' participation in the study (T0) will be started at the stage of canine retraction. At this appointment, 0.019 x 0.025-inch stainless steel archwire will be placed; power arms will be fabricated from 17x25-inch stainless steel on the maxillary first molars and canines. The height of the power arm will be matched with the center of resistance of both canines and molars based on the root length measured on the periapical radiographs. The archwire will be engaged in the canine bracket using stainless steel ligature wire. NiTi coil spring calibrated for force magnitude (400g) at oral temperature will be used to deliver the assigned force will be engaged from the first molars to the canine power arms
Study NCT06668649 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Testing with Questionnaires
Description: Testing with following Questionnaires: pFSS, Polish-language version of Modified Fatigue Impact Scale, Visual Analogue Scale of Fatigue, EQ-5D-5L (EuroQol-5 dimension) questionnaire, Beck Depression Inventory II. In randomly selected 30 patients and 20 controls questionnaires will be administered twice with two weeks interval to assess the test-retest reliability.
Study NCT04635059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pacritinib
Description: Pacritinib is an oral drug which will be taken daily on a 28-day cycle at a dose of 200 mg twice a day (BID).
Study NCT06680583 — intervention group
Intervention type: OTHER
Intervention: physical indicators such as shock index relatives
Description: shock index relatives indicators used in the prediction of cirrhosis with gastrointestinal bleeding
Study NCT06680219 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Crystal Light Raspberry Lemonade: Mix 3 scoops of powder (with scoop provided) with 8-12 oz of water. Enjoy once daily (8-12 oz of water is approximately 236-354 mL of water).
Study NCT06680219 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator
Description: ACTIVE - Nu Biome (Formula #: 95001996; Batch #: EV24931): Mix 3 scoops of powder (with scoop provided) with 8-12 oz of water. Enjoy once daily.~(8-12 oz of water is approximately 236-354 mL of water).
Study NCT06680466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YZJ-4729
Description: Dose Group 1
Study NCT06680466 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: morphine
Description: morphine,
Study NCT06680466 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT06680466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YZJ-4729
Description: Dose Group 2
Study NCT06680466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YZJ-4729
Description: Dose Group 3
Study NCT06680466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YZJ-4729
Description: Dose Group 4
Study NCT06681441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose A
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.
Study NCT06681441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose B
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.
Study NCT06344455 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School Retention and Completion Incentive Savings via Modified Iowa Gambling Task A
Description: Participants will engage in a modified version of the Iowa Gambling Task with visual stimuli that are aligned with the Pé-de-Meia program's requirements. Advantageous cards will display images that are congruent with the program's criteria, while disadvantageous cards will feature images that are contrary to the Pé-de-Meia program's requirements.
Study NCT06344455 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Iowa Gambling Task
Description: The participants will play the unmodified Iowa Gambling Task.
Study NCT06344455 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School Retention and Completion Incentive Savings via Modified Iowa Gambling Task B
Description: The participants will play the modified IGT (Iowa Gambling Task). For the disadvantageous cards, images that align with the requirements of the Pé-de-Meia program will be presented, while for the advantageous cards, images that contradict the criteria of the Pé-de-Meia program will be shown.
Study NCT05380531 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Preoperative Genotyping
Description: Genotype based risk prediction and personalized pain management
Study NCT06681441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.
Study NCT06676488 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Re-Timer glasses
Description: Morning bright light therapy (BLT) will be administered through a safe wearable glasses device called a Re-Timer, purchased from the manufacturer Re-Timer.
Study NCT05951166 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gradient Denervation System
Description: Pulmonary artery denervation (PADN) procedure
Study NCT06676488 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Device
Description: Placebo glasses not providing Bright Light Therapy
Study NCT06680180 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Viscoelastometric assessment of fibrinolysis
Description: Viscoelastometric assessment of whole blood fibrinolysis using supplemental tissue plasminogen activator (tPA) and other agents ex vivo to influence fibrinolysis capacity.
Study NCT06681506 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Metronomic breathing, exercise rehabilitation, external counterpulsation, extracorporeal shock wave.
Description: Phase I rehabilitation(Metronomic breathing，exercise rehabilitation）,Phase II rehabilitation (exercise rehabilitation, external counterpulsation, extracorporeal shock) wave.)
Study NCT06681506 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: bedside rehabilitation and breathing, balance, flexibility, movement rehabilitation
Description: Phase I rehabilitation (bedside rehabilitation, breathing rehabilitation), Phase II rehabilitation (breathing, balance, flexibility, movement)
Study NCT05218668 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fasudil (WP-0512)
Description: Oral fasudil up to 180 mg/day
Study NCT05218668 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fasudil (WP-0512)
Description: Oral fasudil up to 300 mg/day
Study NCT05821426 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eTrieve PE Kit
Description: Patients will be treated with the eTrieve PE Kit
Study NCT06681792 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Climate Change Workshops Based on Protection Motivation Theory
Description: The experimental group will take part in seven weekly workshops. One workshop will last 40 minutes.The workshop to be applied to the experimental group will take place every week and will last 40 minutes. The workshops, which are based on the Protection Motivation Theory, consist of topics such as the balance of nature, climate change, carbon and ecological footprints, reducing the effects of climate change and adaptation workshop, acquiring environmentally friendly behaviour, recycling and the Green School Programme for sustainable environmental education.~The workshops include interactive applications such as students expressing their thoughts on the weekly themes, games, brainstorming, word cloud, planting trees, painting cloth bags, watching videos, making presentations on the themes. Motivation Theory, consist of topics such as the balance of nature, climate change, carbon and ecological footprints, reducing the effects of climate change and adaptation workshop, acquiring enviro
Study NCT06709950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Art therapy
Description: Through music, painting, dance and other forms, art therapy can not only help patients regulate their emotions, relieve anxiety and depression, but also activate different areas of the brain to promote neuroplasticity, thereby promoting the recovery of motor function
Study NCT06709950 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Regular therapy
Description: Standard treatment
Study NCT04894773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Imaginary Resistance Exercises
Description: In imaginary resistance exercises, resistive force is assumed to get applied by the patient after demonstrating some resistive objects and the kind of force exerted by them.
Study NCT04894773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Resisted Exercises
Description: In physical resistance exercises, resistive force is applied to the targeted region by using different and appropriate resistive objects.
Study NCT04661085 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Broader Medical history and clinical tests
Description: Patients will be treated with standard care plus additional blood tests, urine culture and urine flow cytometry,
Study NCT04607850 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ChAdOx1-HPV
Description: Trial vaccine
Study NCT05849259 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dementia Care Quality at Home
Description: Each of the two HBPC practices will identify at least two trained Dementia Care Quality at Home Champions who will be trained in the intervention comprised of 1) a standardized assessment tool to assess PLWD and caregiver needs; 2) seven modules created to optimize the well-being of the PLWD and their caregiver; and 3) regular team-based review of persons participating in the program to address care challenges and a team-based case conference approach to solve these challenges.
Study NCT04607850 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-HPV
Description: Trial vaccine
Study NCT04607850 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline placebo vaccine
Study NCT06221293 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: immunoenzyme analysis
Description: immunoenzyme analysis with EVOLIS system
Study NCT06379477 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Refractive surgeries
Description: after primary phacoemulsification surgery any resulting refractive error surprises will be corrected with different refractive surgery options
Study NCT06019494 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oocyte retrieval with low aspiration flow rate
Description: All follicles will be aspirated with the addition of follicular flushing if necessary (up to 5 times per follicle) with an aspiration flow rate of 0.42 ml/sec.
Study NCT06019494 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oocyte retrieval with high aspiration flow rate
Description: High aspiration flow rate All follicles will be aspirated with the addition of follicular flushing if necessary (up to 5 times per follicle) with an aspiration flow rate of 0.62 ml/sec.
Study NCT05805150 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control Lens (stenfilcon A)
Description: One week wear
Study NCT05805150 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens (senofilcon A)
Description: One week wear
Study NCT05395312 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online blended stepped-care mental well-being platform
Description: Participants in experimental group will be stratified according to their level of anxiety and/or depressive symptoms.~Level 2 (normal range)~* Topic-based personal growth articles, exercises, and chatbots~* Webinars and talks on varied mental health related topics~* Virtual support community~Level 3 (mild to moderate)~* Online self-guided mental well-being training programs, such as mindfulness-based intervention, rumination-focused cognitive behavioural therapy, and transdiagnostic cognitive behavioural therapy~* Offline/online skills-based workshops, questions-and-answers sessions, retreats~Level 4 (severe)~* Online coach-guided mental well-being training programs, such as mindfulness-based intervention, rumination-focused cognitive behavioural therapy, and transdiagnostic cognitive behavioural therapy~* Offline/online group therapy, 4-week group cognitive behavioural therapy or 8-week group mindfulness-based cognitive therapy
Study NCT06349837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Patients will receive treatment with Tislelizumab (200 mg, iv, d1), every 3 weeks for a maximum of 48 months.
Study NCT06349837 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low Dose Radiotherapy
Description: LDRT (d1-d3): 6Gy/3f with conventional external beam radiation.
Study NCT06349837 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiotherapy
Description: Partial SBRT at dose escalation levels: 24Gy/3f, 30Gy/3f, 45Gy/3f.
Study NCT04936594 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS
Description: 1800 pulses of iTBS
Study NCT04936594 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS
Description: MagVenture MagPro x100 device. This will be used as the comparator.
Study NCT05766501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DOR/ISL
Description: FDC tablet of 100 mg doravirine (DOR)/0.25 mg islatravir (ISL) taken once daily
Study NCT06449521 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: BECOME intervention
Description: The intervention, BECOME, includes: a) Evidence-based stress reduction (EBSR): as recommended in the WHO mhGAP guidelines, diaphragmatic breathing and body scan will be used to manage stress and anxiety. b) Behavioral activation (BA): as recommended in the mhGAP guidelines, this evidence-based strategy will increase the time that patients spend engaging in pleasurable activities to both treat depression and increase physical activity, depending on their cognitive and physical capabilities (e.g., going to a neighbor's house for tea or walking to the local market). c) Motivational interviewing (MI): an evidence-based patient-interaction strategy that increases the patient's internal motivation to engage in healthy behaviors (e.g., quit tobacco) both to prompt change (if they are not engaging in healthy behaviors) and maintain them (if they are already engaged in healthy behaviors), as recommended by Package of Essential Noncommunicable disease interventions) PEN protocols.
Study NCT06220279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Description: Each were monitored for pain within 24 hours